Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 3
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

511.3500 1.40 (0.27%)

NSE Sep 11, 2025 15:31 PM

63.89% Gain from 52W Low

Volume: 292.2K

Aarti Drugs Ltd.

29 Oct 2021

511.35

0.27%

Result Update:Aarti Drugs

Hold: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

We believe this trend will continue for the upcoming quarters and therefore recommend HOLD rating 0n the stock with a Target Price of Rs 645/share.

Aarti Drugs Ltd. has an average target of 475.00 from 1 broker.